Covered recipient · General Payments record
BRUCE KLUGHERZ
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2019 · Entire year
$23,952.70
208 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2019 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,800.00 | 7 |
| Food and Beverage | $4,662.58 | 192 |
| Travel and Lodging | $969.32 | 5 |
| Consulting Fee | $500.00 | 1 |
| Education | $20.80 | 3 |
By paying entity
PY2019 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $8,332.14 | 26 |
| Medtronic Vascular, Inc. | $3,680.46 | 43 |
| E.R. Squibb & Sons, L.L.C. | $3,567.82 | 24 |
| Boston Scientific Corporation | $3,553.23 | 17 |
| Novartis Pharmaceuticals Corporation | $2,884.89 | 11 |
| Abbott Laboratories | $354.25 | 7 |
| Cardinal Health 200, LLC | $289.20 | 9 |
| SANOFI-AVENTIS U.S. LLC | $188.98 | 7 |
| ABIOMED | $180.18 | 3 |
| Amgen Inc. | $165.29 | 11 |
| AstraZeneca Pharmaceuticals LP | $157.62 | 11 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $129.12 | 10 |
| Amarin Pharma Inc. | $117.30 | 9 |
| Janssen Pharmaceuticals, Inc | $113.58 | 8 |
| Edwards Lifesciences Corporation | $91.46 | 3 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $63.61 | 5 |
| ASAHI INTECC USA, INC. | $49.36 | 1 |
| Lundbeck LLC | $23.41 | 2 |
| Terumo Medical Corporation | $10.80 | 1 |
Page 3 of 5; records 101–150 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
BRUCE KLUGHERZ
NPI 1417941915 · CMS profile ID 830639
Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease
HORSHAM, PA
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 3 of 5; records 101–150 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1417941915?year=2019&recipient=provider&page=3#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- BRUCE KLUGHERZ, NPI 1417941915, CMS profile ID 830639. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417941915?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- APA 7
- IndustryPayments. (2026). BRUCE KLUGHERZ, NPI 1417941915, CMS profile ID 830639. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417941915?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- Bluebook
- BRUCE KLUGHERZ, NPI 1417941915, CMS profile ID 830639, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1417941915?year=2019&recipient=provider&page=3#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2019
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30
208 matching records · $23,952.70 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 101–150 of 208.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| ABIOMED | $21.98 | 07/11/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676705993 | CMS |
| Amarin Pharma Inc. | $14.46 | 07/09/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 699179355 | CMS |
| PFIZER INC. | $15.66 | 07/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 672629123 | CMS |
| Medtronic Vascular, Inc. | $10.63 | 06/28/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676965157 | CMS |
| Janssen Pharmaceuticals, Inc | $16.19 | 06/26/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 658852465 | CMS |
| PFIZER INC. | $0.86 | 06/26/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 672176955 | CMS |
| PFIZER INC. | $10.01 | 06/25/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 672629127 | CMS |
| PFIZER INC. | $7.90 | 06/25/2019 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 672656471 | CMS |
| Amgen Inc. | $16.61 | 06/24/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 662227937 | CMS |
| ABIOMED | $124.37 | 06/20/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676706011 | CMS |
| PFIZER INC. | $1.16 | 06/20/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 672107417 | CMS |
| PFIZER INC. | $10.28 | 06/20/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 672610433 | CMS |
| Lundbeck LLC | $12.17 | 06/19/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684311633 | CMS |
| Cardinal Health 200, LLC | $37.35 | 06/14/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 658968621 | CMS |
| Abbott Laboratories | $23.02 | 06/12/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 667333075 | CMS |
| SANOFI-AVENTIS U.S. LLC | $107.54 | 06/12/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694080911 | CMS |
| Amarin Pharma Inc. | $14.03 | 06/11/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 699158247 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.99 | 06/10/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 651444679 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $9.31 | 06/07/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 700469485 | CMS |
| Medtronic Vascular, Inc. | $5.17 | 06/05/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676938453 | CMS |
| Novartis Pharmaceuticals Corporation | $2,650.00 | 06/05/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 659569347 | CMS |
| Novartis Pharmaceuticals Corporation | $100.00 | 06/05/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 659569349 | CMS |
| Novartis Pharmaceuticals Corporation | $23.00 | 06/05/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 659569357 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.33 | 06/03/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 685976771 | CMS |
| Boston Scientific Corporation | $15.97 | 05/31/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 663261605 | CMS |
| PFIZER INC. | $15.66 | 05/29/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 672098813 | CMS |
| Medtronic Vascular, Inc. | $156.29 | 05/28/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676956311 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1.59 | 05/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 651444669 | CMS |
| E.R. Squibb & Sons, L.L.C. | $5.77 | 05/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 651444673 | CMS |
| PFIZER INC. | $2,625.00 | 05/22/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673820969 | CMS |
| PFIZER INC. | $15.18 | 05/21/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 672267377 | CMS |
| Medtronic Vascular, Inc. | $58.32 | 05/15/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676926207 | CMS |
| Janssen Pharmaceuticals, Inc | $12.16 | 05/14/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 658852461 | CMS |
| Novartis Pharmaceuticals Corporation | $13.17 | 05/13/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 659569359 | CMS |
| Amgen Inc. | $12.44 | 05/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 662227935 | CMS |
| Medtronic Vascular, Inc. | $3.16 | 05/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676912455 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.67 | 05/06/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 685984601 | CMS |
| PFIZER INC. | $2.61 | 05/06/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 672099913 | CMS |
| Medtronic Vascular, Inc. | $7.20 | 05/03/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676909397 | CMS |
| AstraZeneca Pharmaceuticals LP | $11.56 | 04/30/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 685928933 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $9.33 | 04/29/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 700469487 | CMS |
| Medtronic Vascular, Inc. | $5.97 | 04/26/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676901447 | CMS |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $13.15 | 04/24/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 625153531 | CMS |
| Boston Scientific Corporation | $14.89 | 04/19/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 663261597 | CMS |
| Medtronic Vascular, Inc. | $72.97 | 04/18/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676929395 | CMS |
| PFIZER INC. | $2,625.00 | 04/16/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671981379 | CMS |
| Novartis Pharmaceuticals Corporation | $13.93 | 04/15/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 659569355 | CMS |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $12.59 | 04/12/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 625153533 | CMS |
| PFIZER INC. | $121.00 | 04/11/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671979739 | CMS |
| Amarin Pharma Inc. | $5.90 | 04/09/2019 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 699119555 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $709,435.99 | 11 |
| PY2024 | Recipient | $57,737.00 | 1 |
| PY2024 | Principal investigator | $78,403.47 | 3 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
11 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $17,725.00 | 11/05/2025 | Non-covered Recipient Entity ELLIGO HEALTH RESEARCH, INC | A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event | No dispute reported | 06/30/2026 | 1185545309 |
| Principal investigator 1 | Amgen Inc. | $14,067.80 | 07/08/2025 | Non-covered Recipient Entity ABINGTON MEDICAL SPECIALISTS | A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF) | No dispute reported | 06/30/2026 | 1246638676 |
| Principal investigator 1 | Amgen Inc. | $72,204.00 | 06/26/2025 | Non-covered Recipient Entity ELLIGO HEALTH RESEARCH INC | A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF) | No dispute reported | 06/30/2026 | 1246641113 |
| Principal investigator 1 | Amgen Inc. | $157,749.00 | 06/26/2025 | Non-covered Recipient Entity ELLIGO HEALTH RESEARCH INC | A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity | No dispute reported | 06/30/2026 | 1246641137 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $878.94 | 06/13/2025 | Non-covered Recipient Entity ELLIGO HEALTH RESEARCH, INC | A Phase II, Randomized, Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure in Participants with Atherosclerotic Cardiovascular Disease or Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol | No dispute reported | 06/30/2026 | 1185545305 |
| Principal investigator 1 | Amgen Inc. | $21,952.25 | 06/08/2025 | Non-covered Recipient Entity ABINGTON MEDICAL SPECIALISTS | A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity | No dispute reported | 06/30/2026 | 1246638678 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $7,310.80 | 05/30/2025 | Non-covered Recipient Entity ELLIGO HEALTH RESEARCH, INC | A Phase III Randomised Doubleblind Study to Evaluate the Effect of Balcinrenone Dapagliflozin Compared with Dapagliflozin on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function | No dispute reported | 06/30/2026 | 1185545311 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $106,799.60 | 05/09/2025 | Non-covered Recipient Entity ELLIGO HEALTH RESEARCH, INC | a phase third,randomised,double blind,placebo controlled,eventdriven study to evaluate the effect of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on the risk of incident heart failure and cardiovascular death in participants with increased risk of reveloping heart failure | No dispute reported | 06/30/2026 | 1185545313 |
| Principal investigator 1 | AstraZeneca UK Limited | $129,461.72 | 02/05/2025 | Non-covered Recipient Entity ELLIGO HEALTH RESEARCH, INC | A Phase II, Randomized, Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure in Participants with Atherosclerotic Cardiovascular Disease or Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol | No dispute reported | 06/30/2026 | 1185545307 |
| Principal investigator 1 | Eli Lilly and Company | $4,561.88 | 01/27/2025 | Covered Recipient Teaching Hospital ABINGTON MEMORIAL HOSPITAL | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) | No dispute reported | 06/30/2026 | 1187872165 |
| Principal investigator 1 | Eli Lilly and Company | $176,725.00 | 01/07/2025 | Non-covered Recipient Entity ELLIGO HEALTH RESEARCH INC | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) | No dispute reported | 06/30/2026 | 1187881224 |